The European Falsified Medicines Directive

As of February 9th, the European Falsified Medicines Directive (EU FMD) will become effective.

The EU FMD is put in place to counteract the circulation of falsified medicines in Europe. All medicines require a unique identifier printed on each and every package. In addition, all medicines require record keeping in a central database; only registered medicines can be sold within Europe. The EFMD is embracing the complete pharmaceutical supply chain within Europe; this also includes international wholesalers like Imres.

Imres has taken all necessary precautions and is fully compliant with the EU FMD. This implies for Imres that all European Union (EU) registered medicines will be decommissioned when leaving our GDP warehouse and therefore can only be sold for export outside the EU.

We hope that this information will be of use to you. Please contact us if you need any further assistance. In the interim, if you have any other questions please take a look at the link with Questions and Answers complied directly by the EU.

https://ec.europa.eu/health/sites/health/files/files/falsified_medicines/qa_safetyfeature_en.pdf